skip to main content

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

News

"How antidepressants help bacteria resist antibiotics"
24.01.2023 "How antidepressants help bacteria resist antibiotics" In the Media

Nature

How gut bacteria evade the immune system
06.01.2023 How gut bacteria evade the immune system Press Release
Finding a peptide drug against MRSA
22.12.2022 Finding a peptide drug against MRSA CMFI News

Registration open

Please visit the conference website for

registration

Placeholder background image

Data is transmitted to external servers.


Events

Single-cell biology of bacterial pathogens in host tissues
02.02.2023 Single-cell biology of bacterial pathogens in host tissues Joint Microbiological Colloquium Dirk Bumann More
The E. coli Whole-Cell Modeling Project
06.02.2023 The E. coli Whole-Cell Modeling Project 6:00 pm CMFI Invited Speaker Markus Covert (Stanford University) More
Therapeutic Promise of the Microbiome: The Dr. Paul Janssen Award Symposium
09.02.2023 Therapeutic Promise of the Microbiome: The Dr. Paul Janssen Award Symposium 9:00 am 12:30 pm Symposium Ruth Ley More

About the CMFI

The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases it also damages the microbiome as a whole. 

 

CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.

The Cluster of Excellence CMFI brings together researchers from different disciplines such as infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, and medical history and ethics. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.

The CMFI is one of more than 50 Clusters of Excellence funded by German federal and state governments as part of the Excellence Initiative to sustainably strengthen Germany as a center of science, improve its international competitiveness and make cutting-edge research at German universities visible. In addition to the University of Tübingen, the Max Planck Institute for Biology and the University Hospital Tübingen are involved in the CMFI.

More about the Research